Do NAD+ Injections Actually Work? What the Research Says
NAD+ is a coenzyme involved in hundreds of cellular reactions, its measured levels decline with age, and raising those levels is an active research field. Whether raising them produces measurable benefits in healthy adults is a genuinely open scientific question, with human trials thinner and more mixed than the wellness industry implies. Here is the evidence, sorted.
Reviewed by board-certified physicians · Published 2026-08-28 · Updated 2026-08-28 · 9 min read
Key facts
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to redox reactions and a substrate for enzymes involved in DNA repair and cellular signaling.
Measured NAD+ levels decline with age in multiple tissues, an observation replicated across studies.
Human trials of NAD-raising approaches show that levels can be raised; consistent clinical benefits in healthy adults have not been established.
A 2025 meta-analysis of randomized trials found no significant effect of NAD precursor supplementation on muscle performance measures.
Injectable NAD+ is a compounded preparation, not an FDA-approved drug, with no approved indication.
Most published human data involves oral precursors rather than the injectable form itself.
What does NAD+ actually do in the body?
NAD+ sits near the center of cellular chemistry. As a coenzyme it shuttles electrons in the reactions that convert food into usable chemical fuel, and as a substrate it is consumed by enzyme families with roles in DNA repair (PARPs) and in signaling tied to aging biology (sirtuins). That combination, plus the reproducible observation that measured NAD+ levels decline with age, is why the molecule became a legitimate scientific interest before it became a wellness product.
The inference that the industry sells, that restoring youthful levels restores youthful function, is a hypothesis, not an established result. It is being tested; it has not been proven; and the gap between those two states is where a careful reader should stand.
What have human trials actually shown?
The most solid findings are pharmacological: oral precursors such as nicotinamide riboside reliably raise blood NAD+ levels in humans, with reasonable tolerability in trials. On outcomes, the picture thins fast. Individual studies have reported scattered signals on measures like blood pressure or specific inflammatory markers in specific populations, while other trials in healthy adults report no meaningful functional differences, and a 2025 meta-analysis pooling randomized trials found no significant effect on muscle strength or performance endpoints.
Framed plainly: raising the level is established; the level translating into feeling or performing measurably better in healthy people is not. In medicine, that pattern, biomarker moves, outcomes unproven, is common and is precisely the stage where marketing tends to sprint ahead of data.
Does the injectable form change the evidence picture?
Mostly it changes the route, not the proof. Injectable NAD+ delivers the molecule subcutaneously or intravenously rather than asking the gut to process a precursor, and small studies document measurable pharmacology by these routes. But nearly all outcome research involves oral precursors, so the injectable form inherits an already-thin evidence base secondhand. No injectable NAD+ product is FDA-approved for any indication; what circulates is compounded, prepared per prescription by state-licensed pharmacies under the framework covered in our compounding explainer.
Users of intravenous NAD+ commonly report infusion-rate effects, flushing, chest tightness, nausea during fast drips, which is why slow administration is standard practice in that setting and why some patients and clinicians prefer the subcutaneous route; the comparison is covered in our route guide.
3/mo CHROMA23+ Membership, medication priced separately, every cost shown first.
Three deserve naming. First, the theoretical one debated in the research literature: NAD+ fuels cellular machinery indiscriminately, and whether raising it could feed unwanted cell growth is an open question researchers treat seriously, which is why a personal cancer history belongs in any physician conversation about NAD therapy. Second, the practical one: compounded sterile injectables are only as good as the pharmacy making them, a point underlined by a 2025 recall of one compounder's NAD+ injection over endotoxin contamination. Third, the mundane one: injection-site reactions and the infusion effects above.
None of these is a reason for panic; all are reasons the product is prescription-gated and pharmacy-verified rather than a wellness-shop purchase. Source quality is most of the practical safety question.
So what would a sober summary tell a curious adult?
That the underlying biology is real and interesting; that levels can genuinely be raised; that benefit in healthy adults remains unproven, with the best-pooled evidence to date showing no effect on the endpoints tested; that harms at typical doses appear limited when sourcing is legitimate; and that anyone promising energy, youth, or reversal of aging is selling past the data. If you choose to explore it, do it the way this entire blog recommends for every therapy: through a physician who knows your history, a verifiable state-licensed pharmacy, and expectations calibrated to evidence rather than to testimonials you cannot verify.
And keep perspective: the interventions with overwhelming evidence for the outcomes NAD marketing gestures at, exercise, sleep, weight management, remain undefeated and unglamorous. A reasonable protocol treats those as the foundation and any injectable as, at most, an adjunct under evaluation.
Frequently asked questions
How would I even know if it was doing anything for me?
That is the right question to bring to a physician, and the answer should be concrete: an agreed trial period, defined things you are tracking, and a willingness to stop if nothing moves. Open-ended indefinite use with vague goals is how wellness spending becomes a subscription to nothing.
Is NAD+ the same as NMN or nicotinamide riboside?
They are relatives, not synonyms: NMN and nicotinamide riboside are precursors the body converts toward NAD+, and most human outcome data involves the oral precursors. The distinctions, including the injectable Niagen development, are covered in our Niagen vs NAD+ comparison.
Are NAD+ injections FDA-approved for anything?
No. There is no approved injectable NAD+ product or indication; available versions are compounded preparations under pharmacy law. That does not make them illegitimate; it makes the standard compounded-product disclosure and physician oversight non-negotiable.
Why do so many people online say they feel amazing on it?
Testimony is real experience but weak evidence: expectation effects are strong precisely in the domains involved, energy, mood, focus, and none of it survives blinding in the trials run so far. Neither dismissing people nor mistaking their reports for data is necessary; the trials are the referee.
About CHROMA23®
CHROMA23® is a clinical weight loss platform built on prescription protocols: injectables, oral medicine, and the protocols that come next, under one 3 membership. Every prescription decision is made by an independent, board-certified physician licensed in the patient's state, and every medication is dispensed by a state-licensed pharmacy. The assessment is free. The membership is 3. The medicine is real. The physician is real.
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved. Always consult a board-certified physician about your individual situation. Figures from named clinical trials describe study populations; individual results vary and are not typical.